- Report
- January 2024
- 180 Pages
Global
From €7172EUR$7,500USD£6,146GBP
- Drug Pipelines
- July 2023
- 139 Pages
Global
From €10514EUR$10,995USD£9,009GBP
- Report
- March 2021
- 75 Pages
Global
€21037EUR$22,000USD£18,027GBP
- Report
- April 2021
- 127 Pages
Global
From €10514EUR$10,995USD£9,009GBP
- Clinical Trials
- January 2020
- 500 Pages
Global
From €2295EUR$2,400USD£1,967GBP
- Report
- July 2021
- 117 Pages
Global
From €3200EUR$3,585USD£2,838GBP
Sinemet is a brand name for a combination of two drugs, levodopa and carbidopa, used to treat symptoms of Parkinson's disease. It is a central nervous system (CNS) drug, which works by increasing the amount of dopamine in the brain. It is used to improve muscle control and reduce tremors, stiffness, and slowed movement. It is also used to treat restless legs syndrome and other conditions.
Sinemet is available in both immediate-release and extended-release forms. The extended-release form is designed to provide a steady level of the drug in the body throughout the day. Side effects of Sinemet may include nausea, vomiting, dizziness, and headache.
Sinemet is manufactured by Merck & Co. and is available in many countries around the world. Other companies that produce similar drugs include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more